Localization of peroxisome proliferator-activated receptor alpha (PPARα) and N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) in cells expressing the Ca2+-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampus

Frontiers in Neuroanatomy

Volumn 8, Issue MAR, 2014, Pages

  Rivera, Patricia ^a,b   Arrabal, Sergio ^a,b   Vargas, Antonio ^a   Blanco, Eduardo ^c   Serrano, Antonia ^a,b   Pavón, Francisco J ^a,b   de Fonseca, Fernando Rodríguez ^a,b   Suárez, Juan ^a,b  

^a Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina IBIMA Plataforma Bionand   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF LLEIDA   (Spain)

Author keywords

Calcium binding protein; Confocal microscopy; Hippocampus; Immunohistochemistry; NAPE PLD; PPAR alpha; Rat

Indexed keywords

CALBINDIN; CALRETININ; N ACYL PHOSPHATIDYLETHANOLAMINE PHOSPHOLIPASE D; PARVALBUMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHOLIPASE D; UNCLASSIFIED DRUG;

ADULT; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CELL SUBPOPULATION; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DENTATE GYRUS; EPIFLUORESCENCE MICROSCOPY; HIPPOCAMPUS; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84896998313     PISSN: 16625129     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnana.2014.00012     Document Type: Article

References (63)

1. Aleshin, S., Strokin, M., Sergeeva, M., and Reiser, G. (2013). Peroxisome proliferator-activated receptor (PPAR)p/5, a possible nexus of PPARa-and PPARy-dependent molecular pathways in neurodegenerative diseases: review and novel hypotheses. Neurochem. Int. 63, 322-330. doi: 10.1016/j.neuint.2013.06.012.
2. Baimbridge, K. G., and Miller, J. J. (1982). Immunohistochemical localization of calcium-binding protein in the cerebellum, hippocampal formation and olfactory bulb of the rat. Brain Res. 245, 223-229. doi: 10.1016/0006-8993(82) 90804-6.
3. Baimbridge, K. G., Miller, J. J., and Parkes, C. O. (1982). Calcium-binding protein distribution in the rat brain. Brain Res. 239, 519-525. doi: 10.1016/0006-8993(82)90526-1.
4. Bisogno, T., and Di Marzo, V. (2008). The role of the endocannabinoid system in Alzheimer's disease: facts andhypotheses. Curr. Pharm. Des. 14, 2299-3305. doi: 10.2174/138161208785740027.
5. Bouilleret, V., Schwaller, B., Schurmans, S., Celio, M. R., and Fritschy, J. M. (2000). Neurodegenerative and morphogenic changes in a mouse model of temporal lobe epilepsy do not depend on the expression of the calcium-binding proteins parvalbumin, calbindin, or calretinin. Neuroscience 97, 47-58. doi: 10.1016/S0306-4522(00)00017-8.
6. Braissant, O., Foufelle, F., Scotto, C., Dauta, M., and Wahli, W. (1996). Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137, 354-366.
7. Busquets-Garcia, A., Puighermanal, E., Pastor, A., de la Torre, R., Maldonado, R., and Ozaita, A. (2011). Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses. Biol. Psychiatry 70, 479-486. doi: 10.1016/j.biopsych.2011.04.022.
8. Calignano, A., La Rana, G., Giuffrida, A., and Piomelli, D. (1998). Control of pain initiation by endogenous cannabinoids. Nature 394, 277-281. doi: 10.1038/28393.
9. Cates, J. M., Coffing, B. N., Harris, B. T., and Black, C. C. (2006). Calretinin expression in tumors of adipose tissue. Hum. Pathol. 37, 312-321. doi: 10.1016/j.humpath.2005.11.006.
10. Celio, M. R. (1986). Parvalbumin in most gamma-aminobutyric acid-containing neurons of the rat cerebral cortex. Science 231, 995-997. doi: 10.1126/sci-ence.3945815.
11. Celio, M. R. (1990). Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience 35, 375-475. doi: 10.1016/0306-4522(90)90091-H
12. Combs, C. K., Bates, P., Karlo, J. C., and Landreth, G. E. (2001). Regulation of beta-amyloid stimulated proinflammatory responses by peroxisome proliferator-activated receptor alpha. Neurochem. Int. 39, 449-457. doi: 10.1016/S0197-0186(01)00052-3.
13. Cullingford, T. E., Bhakoo, K., Peuchen, S., Dolphin, C. T., Patel, R., and Clark, J. B. (1998). Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system. J. Neurochem. 70, 1366-1375. doi: 10.1046/j.1471-4159.1998.70041366.x
14. Di Marzo, V., De Petrocellis, L., Sepe, N., and Buono, A. (1996). Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells. Biochem. J. 316, 977-984.
15. Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J. C., et al. (1994). Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372, 686-691. doi: 10.1038/372686a0.
16. Dumas, T. C., Powers, E. C., Tarapore, P. E., and Sapolsky, R. M. (2004). Overexpression of calbindin D(28k) in dentate gyrus granule cells alters mossy fiber presynaptic function and impairs hippocampal-dependent memory. Hippocampus 14, 701-709. doi: 10.1002/hipo.10210.
17. Egertova, M., Simon, G. M., Cravatt, B. F., and Elphick, M. R. (2008). Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: a new perspective on N-acylethanolamines as neural signaling molecules. J. Comp. Neurol. 506, 604-615. doi: 10.1002/cne.21568.
18. Esposito, E., Impellizzeri, D., Mazzon, E., Paterniti, I., and Cuzzocrea, S. (2012). Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease. PLoS ONE 7:e41880. doi: 10.1371/journal.pone.0041880.
19. Freund, T. F. (2003). Interneuron diversity series: rhythm and mood in perisomatic inhibition. TrendsNeurosci.26,489-495. doi: 10.1016/S0166-2236(03)00227-3.
20. Galan-Rodriguez, B., Suarez, J., Gonzalez-Aparicio, R., Bermudez-Silva, F. J., Maldonado, R., Robledo, P., et al. (2009). Oleoylethanolamide exerts partial and dose-dependent neuroprotection of substantia nigra dopamine neurons. Neuropharmacology 56, 653-664. doi: 10.1016/j.neuropharm.2008. 11.006.
21. Garcia-Segura, L. M., Baetens, D., Roth, J., Norman, A. W., and Orci, L. (1984). Immunohistochemical mapping of calcium-binding protein immunoreactivity in the rat central nervous system. Brain Res. 296, 75-86. doi: 10.1016/0006-8993(84)90512-2.
22. Garg, P., Duncan, R. S., Kaja, S., Zabaneh, A., Chapman, K. D., and Koulen, P. (2011). Lauroylethanolamide and linoleoylethanolamide improve functional outcome in a rodent model for stroke. Neurosci. Lett. 492, 134-138. doi: 10.1016/j.neulet.2011.01.073.
23. Greene-Schloesser, D., Payne, V., Peiffer, A. M., Hsu, F. C., Riddle, D. R., Zhao, W., et al. (2014). The peroxisomal proliferator-activated receptor (PPAR) a agonist, fenofibrate, prevents fractionated whole-brain irradiation-induced cognitive impairment. Radiat. Res. 181, 33-44. doi: 10.1667/RR13202.1.
24. Gulyas, A. I., Miettinen, R., Jacobowitz, D. M., and Freund, T. F. (1992). Calretinin is present in non-pyramidal cells of the rat hippocampus-I. A new type of neuron specifically associated with the mossy fibre system. Neuroscience 48, 1-27. doi: 10.1016/0306-4522(92)90334-X
25. Gulyas, A. I., Toth, K., Danos, P., and Freund, T. F. (1991). Subpopulations of GABAergic neurons containing parvalbumin, calbindin D28k, and chole-cystokinin in the rat hippocampus. J. Comp. Neurol. 312, 371-378. doi: 10.1002/cne.903120305.
26. Hajieva, P., Kuhlmann, C., Luhmann, H. J., and Behl, C. (2009). Impaired calcium homeostasis in aged hippocampal neurons. Neurosci. Lett. 451, 119-123. doi: 10.1016/j.neulet.2008.11.068.
27. Heizmann, C. W. (1984). Parvalbumin, a relaxing factor in muscle and a neuronal marker in brain. Prog. Clin. Biol. Res. 168, 205-210.
28. Inoue, I., Goto, S., Matsunag, T., Nakajima, T., Awata, T., Hokari, S., et al. (2001). The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismu-tase and decrease p22phox message expressions in primary endothelial cells. Metabolism 50, 3-11. doi: 10.1053/meta.2001.19415.
29. Kandel, E. R., and Spencer, W. A. (1961). The pyramidal cell during hippocampal seizure. Epilepsia2, 63-69. doi: 10.1111/j.1528-1167.1961.tb06247.x
30. Karadi, K., Janszky, J., Gyimesi, C., Horvath, Z., Lucza, T., Doczi, T., et al. (2012). Correlation between calbindin expression in granule cells of the resected hippocampal dentate gyrus and verbal memory in temporal lobe epilepsy. Epilepsy Behav. 25, 110-119. doi: 10.1016/j.yebeh.2012.06.007.
31. Khasabova, I. A., Xiong, Y., Coicou, L. G., Piomelli, D., and Seybold, V. (2012). Peroxisome proliferator-activated receptor a mediates acute effects of palmi-toylethanolamide on sensory neurons. J. Neurosci. 32, 12735-12743. doi: 10.1523/JNEUR0SCI.0130-12.2012.
32. Koch, M., Kreutz, S., Bottger, C., Benz, A., Maronde, E., Ghadban, C., et al. (2011). Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-a. Neurotox. Res. 19, 330-340. doi: 10.1007/s12640-010-9166-2.
33. Kosaka, T., Katsumaru, H., Hama, K., Wu, J. Y., and Heizmann, C. W. (1987). GABAergic neurons containing the Ca2+-binding protein parvalbumin in the rat hippocampus and dentate gyrus. Brain Res. 419, 119-130. doi: 10.1016/0006-8993(87)90575-0.
34. Leung, D., Saghatelian, A., Simon, G. M., and Cravatt, B. F. (2006). Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. Biochemistry 45, 4720-4726. doi: 10.1021/bi060163l
35. Lombardi, G., Miglio, G., Varsaldi, F., Minassi, A., and Appendino, G. (2007). Oxyhomologation of the amide bond potentiates neuroprotective effects of the endolipid N-palmitoylethanolamine. J. Pharmacol. Exp. Ther. 320, 599-606. doi: 10.1124/jpet.106.112987.
36. Magloczky, Z., Halasz, P., Vajda, J., Czirjak, S., and Freund, T. F. (1997). Loss of Calbindin-D28K immunoreactivity from dentate granule cells in human temporal lobe epilepsy. Neuroscience 76, 377-385. doi: 10.1016/S0306-4522(96)00440-X
37. Miettinen, R., Gulyas, A. I., Baimbridge, K. G., Jacobowitz, D. M., and Freund, T. F. (1992). Calretinin is present in non-pyramidal cells of the rat hippocampus-II. Co-existence with other calcium binding proteins and GABA. Neuroscience 48, 29-43. doi: 10.1016/0306-4522(92)90335-Y
38. Molinari, S., Battini, R., Ferrari, S., Pozzi, L., Killcross, A. S., Robbins, T. W., et al. (1996). Deficits in memory and hippocampal long-term potentiation in mice with reduced calbindin D28K expression. Proc. Natl. Acad. Sci. U.S.A. 93, 8028-8033. doi: 10.1073/pnas.93.15.8028.
39. Moreno, S., Farioli-Vecchioli, S., and Ceru, M. P. (2004). Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 123, 131-145. doi: 10.1016/j.neuroscience.2003.08.064.
40. Murray, A. J., Sauer, J. F., Riedel, G., McClure, C., Ansel, L., Cheyne, L., et al. (2011). Parvalbumin-positive CA1 interneurons are required for spatial working but not for reference memory. Nat. Neurosci. 14, 297-299. doi: 10.1038/nn.2751.
41. Nakamura, Y., Nakahama, T., Ushiwata, A., Takeda, M., and Nakaya, K. (1980). Isolation and partial characterization of an acidic calcium-binding protein from synaptic plasma membranes of rat brain. FEBS Lett. 112, 155-158. doi: 10.1016/0014-5793(80)80169-4.
42. Nakazawa, K., Zsiros, V., Jiang, Z., Nakao, K., Kolata, S., Zhang, S., et al. (2012). GABAergic interneuron origin of schizophrenia pathophysiology. Neuropharmacology 62, 1574-1583. doi: 10.1016/j.neuropharm.2011.01.022.
43. Nyilas, R., Dudok, B., Urban, G. M., Mackie, K., Watanabe, M., Cravatt, B. F., et al. (2008). Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals. J. Neurosci. 28, 1058-1063. doi: 10.1523/JNEUR0SCI.5102-07.2008.
44. Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., and Ueda, N. (2004). Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem. 279, 5298-5305. doi: 10.1074/jbc.M306642200.
45. Okamoto, Y., Wang, J., Morishita, J., and Ueda, N. (2007). Biosynthetic pathways of the endocannabinoid anandamide. Chem. Biodivers. 4, 1842-1857. doi: 10.1002/cbdv.200790155.
46. Paxinos, G., and Watson, C. (2007). The Rat Brain in Stereotaxic Coordinates, 6th Edn. Sidney: Academic Press.
47. Rodriguez de Fonseca, F., Navarro, M., Gomez, R., Escuredo, L., Nava, F., Fu, J., et al. (2001). An anorexic lipid mediator regulated by feeding. Nature 414, 209-212. doi: 10.1038/35102582.
48. Ruttimann, E., Vacher, C. M., Gassmann, M., Kaupmann, K., Van der Putten, H., and Bettler, B. (2004). Altered hippocampal expression of calbindin-D-28k and calretinin in GABA(B(1))-deficient mice. Biochem. Pharmacol. 68, 1613-1620. doi: 10.1016/j.bcp.2004.07.019.
49. Santos, M. J., Quintanilla, R. A., Toro, A., Grandy, R., Dinamarca, M. C., Godoy, J. A., et al. (2005). Peroxisomal proliferation protects from beta-amyloid neurodegeneration. J. Biol. Chem. 280, 41057-41068. doi: 10.1074/jbc.M505160200.
50. Schmid, H. H. (2000). Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively? Chem. Phys. Lipids 108, 71-87. doi: 10.1016/S0009-3084(00)00188-2.
51. Schwartzkroin, P. A., and Kunkel, D. D. (1985). Morphology of identified interneurons in the CA1 regions of guinea pig hippocampus. J. Comp. Neurol. 232, 205-218. doi: 10.1002/cne.902320206.
52. Scuderi, C., Valenza, M., Stecca, C., Esposito, G., Carratu, M. R., and Steardo, L. (2012). Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activatedreceptor-a. J. Neuroinflammation 9:49. doi: 10.1186/17422094-9-49.
53. Seebacher, F., and Walter, I. (2012). Differences in locomotor performance between individuals: importance of parvalbumin, calcium handling and metabolism. J. Exp. Biol. 215, 663-670. doi: 10.1242/jeb.066712.
54. Soontornniyomkij, V., Risbrough, V. B., Young, J. W., Soontornniyomkij, B., Jeste, D. V., and Achim, C. L. (2012). Hippocampal calbindin-1 immunoreactivity correlates of recognition memory performance in aged mice. Neurosci. Lett. 516, 161-165. doi: 10.1016/j.neulet.2012.03.092.
55. Suardiaz, M., Estivill-Torrus, G., Goicoechea, C., Bilbao, A., and Rodriguez de Fonseca, F. (2007). Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain. Pain 133, 99-110. doi: 10.1016/j.pain.2007.03.008.
56. Suarez, J., Bermudez-Silva, F. J., Mackie, K., Ledent, C., Zimmer, A., Cravatt, B. F., et al. (2008). Immunohistochemical description ofthe endogenous cannabinoid system in the rat cerebellum and functionally related nuclei. J. Comp. Neurol. 509,400-421. doi: 10.1002/cne.21774.
57. Suarez, J., Davila, J. C., Real, M. A., and Guirado, S. (2005). Distribution of GABA, calbindin and nitric oxide synthase in the developing chick entopallium. Brain Res. Bull. 66, 441-444. doi: 10.1016/j.brainresbull.2005.02.014.
58. Suarez, J., Davila, J. C., Real, M. A., Guirado, S., and Medina, L. (2006). Calcium-binding proteins, neuronal nitric oxide synthase, and GABA help to distinguish different pallial areas in the developing and adult chicken. I. Hippocampal formation and hyperpallium. J. Comp. Neurol. 497, 751-771. doi: 10.1002/cne.21004.
59. Sun, Y., Alexander, S. P., Garle, M. J., Gibson, C. L., Hewitt, K., Murphy, S. P., et al. (2007). Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism. Br. J. Pharmacol. 152, 734-743. doi: 10.1038/sj.bjp.0707478.
60. Verret, L., Mann, E. O., Hang, G. B., Barth, A. M., Cobos, I., Ho, K., et al. (2012). Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 149, 708-721. doi: 10.1016/j.cell.2012. 02.046.
61. Wouterlood, F. G., Grosche, J., and Hartig, W. (2001). Co-localization of calretinin and calbindin in distinct cells in the hippocampal formation of the rat. Brain Res. 922, 310-314. doi: 10.1016/S0006-8993(01) 03220-6.
62. Zhou, Y., Yang, L., Ma, A., Zhang, X., Li, W., Yang, W., et al. (2012). Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor a. Neuropharmacology 63, 242-249. doi: 10.1016/j.neurophaxm.2012.03.008.
63. Zimmermann, L., and Schwaller, B. (2002). Monoclonal antibodies recognizing epitopes of calretinins: dependence on Ca2+-binding status and differences in antigen accessibility in colon cancer cells. Cell Calcium 31, 13-25. doi: 10.1054/ceca.2001.0255